Cross-protection against challenge with Puumala virus after immunization with nucleocapsid proteins from different hantaviruses

Journal of Virology

Volumn 76, Issue 13, 2002, Pages 6669-6677

  De Carvalho Nicacio, Cristina ^a   Gonzalez Della Valle, Marcelo ^a   Padula, Paula ^a   Björling, Ewa ^a   Plyusnin, Alexander ^a   Lundkvist, Åke ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOCAPSID PROTEIN;

ARTICLE; CELLULAR IMMUNITY; CROSS REACTION; CRUSH SYNDROME; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HEMORRHAGIC FEVER; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PUUMALA VIRUS; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, VIRAL; ARVICOLINAE; CROSS REACTIONS; HANTAVIRUS; HANTAVIRUS INFECTIONS; HEMORRHAGIC FEVER WITH RENAL SYNDROME; NUCLEOCAPSID; PUUMALA VIRUS; RECOMBINANT PROTEINS; T-LYMPHOCYTES; VACCINATION; VIRAL VACCINES;

EID: 0036278323     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.13.6669-6677.2002     Document Type: Article

References (44)

1. Cross-reactive immunity among different serotypes of virus causing haemorrhagic fever with renal syndrome
2. Cell-mediated immunity to virus causing haemorrhagic fever with renal syndrome: Generation of cytotoxic T lymphocytes
3. Genetic analysis of wild-type Dobrava hantavirus in Slovenia: Co-existence of two distinct genetic lineages within the same natural focus
4. Genetic and antigenic properties of Dobrava virus: A unique member of the Hantavirus genus, family Bunyaviridae
5. Erological divergence of Dobrava and Saaremaa hantaviruses: Evidence for two distinct serotypes
6. Modifying the cellular transport of DNA-based vaccines alters the immune response to hantavirus nucleocapsid protein
7. A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus
8. A neutralizing recombinant human antibody Fab fragment against Puumala hantavirus
9. T-helper and humoral responses to Puumala hantavirus nucleocapsid protein: Identification of T-helper epitopes in a mouse model
10. A major antigenic domain for the human humoral response to Puumala virus nucleocapsid protein is located at the amino-terminus
11. Hantavirus pulmonary syndrome: CD8+ and CD4+ cytotoxic T lymphocytes to epitopes on Sin Nombre virus nucleocapsid protein isolated during acute illness
12. Strategies for epitope analysis using peptide synthesis
13. DNA vaccination with the Hantaan virus M gene protects hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in rhesus monkeys
14. DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against Seoul virus infection
15. Vaccines against hantaviruses
16. Distribution and genetic heterogeneity of Puumala virus in Sweden
17. Hantaviruses: History and overview
18. Replication of hantaviruses
19. Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing Hantavirus structural genes in hamsters
20. Puumala (PUU) hantavirus strain differences and insertion positions in the hepatitis B virus core antigen influence B-cell immunogenicity and protective potential of core-derived particles
21. Hantavirus infections and their prevention
22. Genetic characterization and phylogeny of Andes virus and variants from Argentina and Chile
23. Mapping of B-cell determinants in the nucleocapsid protein of Puumala virus: Definition of epitopes specific for acute immunoglobulin G recognition in humans
24. Cell culture adaptation of Puumala hantavirus changes the infectivity for its natural reservoir, Clethrionomys glareolus, and leads to accumulation of mutants with altered genomic RNA S segment
25. Antigenic variation of European haemorrhagic fever with renal syndrome virus strains characterized using bank vole monoclonal antibodies
26. Sensitive detection of hantaviruses by biotin-streptavidin enhanced immunoassays based on bank vole monoclonal antibodies
27. Characterization of Puumala virus nucleocapsid protein: Identification of B-cell epitopes and domains involved in protective immunity
28. Characterization of Tula virus antigenic determinants defined by monoclonal antibodies raised against baculovirus-expressed nucleocapsid protein
29. Clinical evaluation of a vaccinia-vectored Hantaan virus vaccine
30. Persistent hantavirus infections: Characteristics and mechanisms
31. Development and evaluation of a solid-phase enzyme immunoassay based on Andes hantavirus recombinant nucleoprotein
32. Puumala hantavirus genome in patients with nephropathia epidemica: Correlation of PCR positivity with HLA haplotype and link to viral sequences in local rodents
33. Hantavirus infections in Europe
34. Virus evolution and genetic diversity of hantaviruses and their rodent hosts
35. Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants
36. Preparation of candidate vaccinia-vectored vaccines for haemorrhagic fever with renal syndrome
37. Dobrava hantavirus causes hemorrhagic fever with renal syndrome in central Europe and is carried by two different Apodemus mice species
38. New chimaeric hepatitis B virus core particles carrying hantavirus (serotype Puumala) epitopes: Immunogenicity and protection against virus challenge
39. Chimaeric HBV core particles carrying a defined segment of Puumala hantavirus nucleocapsid protein evoke protective immunity in an animal model
40. + CTL epitopes on nucleocapsid protein
41. Isolation and characterization of a hantavirus from Lemmus sibiricus: Evidence for host switch during hantavirus evolution
42. Antigenic properties and diagnostic potential of Puumala virus nucleocapsid protein expressed in insect cells
43. Immunity to Hantavirus challenge in Meriones unguiculatus induced by vaccinia-vectored viral proteins
44. Protective immunity of Hantaan virus nucleocapsid and envelope protein studied using baculovirus-expressed proteins